By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Santarus Inc. 

10590 West Ocean Air Drive
Suite 200
San Diego  California  92130  U.S.A.
Phone: 858-314-5700 Fax: 858-314-5701



Company News
Salix Pharmaceuticals, Ltd. (SLXP) Completes Acquisition Of Santarus Inc. (SNTS) 1/3/2014 9:10:47 AM
Santarus Inc. (SNTS) Announces Availability Of Amended Tender Offer Materials 12/30/2013 8:28:34 AM
Santarus Inc. (SNTS) Initiates Phase IIa Study With SAN-300 In Patients With Active Rheumatoid Arthritis 12/23/2013 9:18:14 AM
Salix Pharmaceuticals, Ltd. (SLXP) Announces Expiration Of Hart-Scott-Rodino Waiting Period For Acquisition Of Santarus Inc. (SNTS) 12/10/2013 9:56:47 AM
Salix Pharmaceuticals, Ltd. (SLXP) Commences Cash Tender Offer For All Outstanding Shares Of Santarus Inc. (SNTS) 12/3/2013 8:57:53 AM
Pharming Group (PHGUF.PK) and Santarus Inc. (SNTS) Announce New Data From Open-Label Repeat Treatment Study With Rucomest 11/8/2013 9:08:34 AM
Santarus Inc. (SNTS) and Pharming Group (PHGUF.PK) Announce New Data From Open-Label Repeat Treatment Study With RUCONEST (Recombinant Human C1 Esterase Inhibitor) 11/8/2013 7:51:26 AM
Santarus Inc. (SNTS) Reports Third Quarter 2013 Financial Results 11/8/2013 7:46:31 AM
Salix Pharmaceuticals, Ltd. (SLXP) Bags Santarus Inc. (SNTS) for $2.6 Billion to Beef Up Gastro Drug Line-Up 11/8/2013 6:54:22 AM
Santarus Inc. (SNTS) to Hold Third Quarter 2013 Financial Results Conference Call on November 7 10/28/2013 6:28:39 AM